Trial Profile
Phase III Multicentric Study Evaluating the Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2023
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Congenital abnormalities
- Focus Therapeutic Use
- 19 Aug 2016 New trial record